This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


reputable news agency


AstraZeneca mulls spinning off China activities: FT

Credit: Unsplash/CC0 Public Domain

Anglo-Swedish drugmaker AstraZeneca could spin off its Chinese division and list it in Hong Kong to minimize China-related risks, the Financial Times reported on Monday.

The company started discussions several months ago, the business daily said citing people familiar with the talks.

AstraZeneca declined to comment.

According to the FT, the drugmaker was seeking to diminish the risk of any potential Chinese crackdown on .

© 2023 AFP

Citation: AstraZeneca mulls spinning off China activities: FT (2023, June 19) retrieved 18 July 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Comcast reportedly no longer in deal talks with Fox


Feedback to editors